Latest News - BioMedReports.com

Latest News

Filter

Display #

#

1

Collaboration Is The Name of The Game

2

FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs

3

Head of FDA's Device Division Resigns

4

OSI Pharma Announces More Phase 3 Results for Tarceva

5

Maxygen Announces Second Quarter 2009 Earnings Release Date

6

Nephros (OTC:NEPH) Completes $1.25 Million Private Placement

7

Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic

8

Elron Receives FDA Clearance for Insulin Delivery System

9

Teva Reports Second Quarter 2009 Results

10

Phase Forward Reports Second Quarter 2009 Results

11

MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 3, 2009

12

Inhibitex to Host Conference Call to Report Second Quarter 2009 Financial Results on August 11, 2009

13

Phase Forward Acquires Maaguzi LLC, Innovative Provider of Web-Based Electronic Patient Reported Outcomes (ePRO) and Late Phase Solutions

14

Vertex Pharmaceuticals Announces the Date of its Second Quarter 2009 Financial Results Conference Call and Webcast

15

FDA Calendar, Clinical Trials, FDA Decisions

16

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

17

International Drug and Explosives Detection Firm IDenta Corp. CEO Reports on Future Direction of Company

18

Cannabis Science to Apply to the FDA to Utilize Their Fast Track Procedures to Help Speed the Approval of Its Cannabinoid Medicines in Treatment of H1N1 Swine Flu as AP Report Predicts Swine Flu Could Hit up to 40 Percent in the USA

19

SciClone Pharmaceuticals Expands Portfolio by Licensing Ondansetron RapidFilmTM for Chinese Market

20

Flanders Corp. to Announce Second Quarter 2009 Financial Results on July 30th

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 65

Sign Up For Phone Alerts